MENU
IMNN
Stock ticker:
PRICE
CHANGE
CAPITALIZATION

Imunon (IMNN) Ownership - Who owns Imunon?

Profile

Industry
Medical Specialties
Address
997 Lenox Drive
Phone
+1 609 896-9100
Employees
33
Web
https://www.imunon.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
15.26M
P/E Ratio
N/A
Total Cash
5.31M
Projected Growth
N/A
Total Debt
1.39M
Revenue
N/A
Risk (Beta)
2.11
Dividend Yield
N/A
Total Cash/Share
0.37
Total Debt/Equity
12.33
Revenue/Share
null USD as % of share price

Fundamentals

IMNN
Capitalization
15.3M
P/E Ratio
N/A
Risk (Beta)
2.11
Dividend Yield
N/A
Total Cash
5.31M
Total Cash/Share
0.37
Total Debt
1.39M
Total Debt/Equity
12.33
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
3.74M
P/B Ratio
4.08
Cash Flow
N/A
Earnings
-1.91
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
94K
Current Ratio
1.51
Current Revenue Per Employee
4032.26
Dividends Per Share - Security
N/A
EBITDA
-18.66M
Float
N/A
Float - Current
N/A
Gross Income Margin
100.00
Revenue To Assets
-94.15
Shares Held By Institutions
419K
Shares Outstanding - Current
14.4M
Total Liabilities
5.95M
Total Volume MTD
N/A
Value
N/A
Gain YTD
47.044
View a ticker or compare two or three
IMNN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a company which engages in the provision of oncology drug development services

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
997 Lenox Drive
Phone
+1 609 896-9100
Employees
33
Web
https://www.imunon.com